|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
GB8719963D0
(en)
|
1987-08-24 |
1987-09-30 |
Cattaneo A |
Recombinant dna products
|
|
US5831034A
(en)
|
1987-11-13 |
1998-11-03 |
Hermann Katinger |
Human monoclonal anti-HIV-I-antibodies
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
EP0642585B1
(en)
|
1992-05-18 |
2005-12-28 |
Genentech, Inc. |
Activation of oligomerizing receptors by using fused receptor ligands
|
|
US6476198B1
(en)
|
1993-07-13 |
2002-11-05 |
The Scripps Research Institute |
Multispecific and multivalent antigen-binding polypeptide molecules
|
|
UA40577C2
(uk)
|
1993-08-02 |
2001-08-15 |
Мерк Патент Гмбх |
Біспецифічна молекула, що використовується для лізису пухлинних клітин, спосіб її одержання, моноклональне антитіло (варіанти), фармацевтичний препарат, фармацевтичний набір (варіанти), спосіб видалення пухлинних клітин
|
|
AU697387C
(en)
|
1994-09-16 |
2006-03-02 |
Austin Research Institute Cancer and Anti-inflammatory Syndicate No 1 |
Polypeptides with Fc binding ability
|
|
US5874540A
(en)
|
1994-10-05 |
1999-02-23 |
Immunomedics, Inc. |
CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
|
|
IL111196A0
(en)
|
1994-10-07 |
1994-12-29 |
Yeda Res & Dev |
Peptides and pharmaceutical compositions comprising them
|
|
US6808709B1
(en)
|
1994-12-30 |
2004-10-26 |
The Regents Of The University Of California |
Immunoglobulins containing protection proteins and their use
|
|
US6165463A
(en)
|
1997-10-16 |
2000-12-26 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
MX9708008A
(es)
|
1995-04-19 |
1998-03-31 |
Polymun Scient Immunbio Forsch |
Anticuerpos monoclonales contra vih-1 y vacunas hechas de los mismos.
|
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
|
US8212004B2
(en)
|
1999-03-02 |
2012-07-03 |
Human Genome Sciences, Inc. |
Neutrokine-alpha fusion proteins
|
|
US6045774A
(en)
*
|
1997-01-10 |
2000-04-04 |
Epicyte Pharmaceutical Inc. |
J chain polypeptide targeting molecule linked to an imaging agent
|
|
EP1015493A1
(en)
|
1997-01-10 |
2000-07-05 |
EPIcyte Pharmaceutical, Inc. |
Novel epithelial tissue targeting agent
|
|
US20040009166A1
(en)
|
1997-04-30 |
2004-01-15 |
Filpula David R. |
Single chain antigen-binding polypeptides for polymer conjugation
|
|
WO1999054484A1
(en)
|
1998-04-20 |
1999-10-28 |
The Regents Of The University Of California |
Modified immunoglobulin molecules and methods for use thereof
|
|
SK288176B6
(sk)
|
1999-01-07 |
2014-04-02 |
Zymogenetics, Inc. |
Farmaceutický prostriedok obsahujúci fúzny proteín, izolovaná molekula polynukleotidu, expresný vektor, kultivovaná bunka, spôsob prípravy polypeptidu a izolovaný polypeptid
|
|
WO2000061637A1
(en)
|
1999-04-14 |
2000-10-19 |
Smithkline Beecham Corporation |
Erythropoietin receptor antibodies
|
|
EP1194167B1
(en)
|
1999-06-09 |
2009-08-19 |
Immunomedics, Inc. |
Immunotherapy of autoimmune disorders using antibodies which target b-cells
|
|
AU6781700A
(en)
|
1999-08-17 |
2001-03-13 |
Health Research Institute |
Genetic system and self-cleaving inteins derived therefrom, bioseparations and protein purification employing same, and methods for determining critical, generalizable amino acid residues for varying intein activity
|
|
NZ517202A
(en)
|
1999-08-24 |
2004-05-28 |
Medarex Inc |
Human CTLA-4 antibodies and their uses
|
|
US20050287153A1
(en)
|
2002-06-28 |
2005-12-29 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
ES2637801T3
(es)
|
2000-04-11 |
2017-10-17 |
Genentech, Inc. |
Anticuerpos multivalentes y usos de los mismos
|
|
US20020168367A1
(en)
|
2000-04-28 |
2002-11-14 |
Planet Biotechnology Incorporated |
Novel immunoadhesins for treating and preventing viral and bacterial diseases
|
|
US7951378B2
(en)
|
2000-04-28 |
2011-05-31 |
Planet Biotechnology Inc. |
Immunoadhesin comprising a chimeric ICAM-1 molecule produced in a plant
|
|
US7947275B2
(en)
|
2000-05-10 |
2011-05-24 |
Signe Biopharma, Inc. |
Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
|
|
AU2001277531A1
(en)
|
2000-07-10 |
2002-01-21 |
Novartis Ag |
Bifunctional molecules and vectors complexed therewith for targeted gene delivery
|
|
WO2005056601A2
(en)
|
2003-12-05 |
2005-06-23 |
Schreiber John R |
Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse?
|
|
JP2004514423A
(ja)
|
2000-09-07 |
2004-05-20 |
シュライバー， ジョン アール． |
トランスジェニックｘｅｎｏｍｏｕｓｅ（登録商標）から獲得されるｐｅｕｄｏｍｏｎａｓａｅｒｕｇｉｎｏｓａｌｐｓに対するヒト抗体
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US7138496B2
(en)
|
2002-02-08 |
2006-11-21 |
Genetastix Corporation |
Human monoclonal antibodies against human CXCR4
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
KR100900176B1
(ko)
|
2001-03-07 |
2009-06-02 |
메르크 파텐트 게엠베하 |
하이브리드 이소타입 항체 부분구조를 포함하는 단백질을위한 발현 기술
|
|
US7402312B2
(en)
*
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
|
US20050129616A1
(en)
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
NZ513418A
(en)
|
2001-08-07 |
2004-04-30 |
Univ Massey |
Vaccine comprising proteins from mycobacterium paratuberculosis
|
|
ES2559002T3
(es)
|
2001-10-23 |
2016-02-10 |
Psma Development Company, L.L.C. |
Anticuerpos contra PSMA
|
|
CA2476166C
(en)
|
2002-02-14 |
2011-11-15 |
Immunomedics, Inc. |
Anti-cd20 antibodies and fusion proteins thereof and methods of use
|
|
ATE477276T1
(de)
|
2002-03-01 |
2010-08-15 |
Immunomedics Inc |
Internalisierung von anti cd74 monoklonalen antikörpern und deren verwendungen
|
|
CA2478047C
(en)
|
2002-03-01 |
2014-01-21 |
Immunomedics, Inc. |
Rs7 antibodies
|
|
IL164287A0
(en)
|
2002-04-12 |
2005-12-18 |
Medarex Inc |
Methods of treatment using ctla-4 antibodies
|
|
CA2489467C
(en)
|
2002-06-14 |
2015-02-24 |
Immunomedics, Inc. |
Humanized monoclonal antibody hpam4
|
|
US7601351B1
(en)
*
|
2002-06-26 |
2009-10-13 |
Human Genome Sciences, Inc. |
Antibodies against protective antigen
|
|
PT2314629E
(pt)
|
2002-07-18 |
2014-01-22 |
Merus B V |
Produção recombinante de misturas de anticorpos
|
|
WO2004013180A2
(en)
|
2002-08-01 |
2004-02-12 |
Immunomedics, Inc. |
Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
|
|
WO2004028339A2
(en)
|
2002-09-27 |
2004-04-08 |
Brigham And Women's Hospital, Inc. |
Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues
|
|
US7541440B2
(en)
|
2002-09-30 |
2009-06-02 |
Immunomedics, Inc. |
Chimeric, human and humanized anti-granulocyte antibodies and methods of use
|
|
US20050014932A1
(en)
|
2003-05-15 |
2005-01-20 |
Iogenetics, Llc |
Targeted biocides
|
|
AR044388A1
(es)
|
2003-05-20 |
2005-09-07 |
Applied Molecular Evolution |
Moleculas de union a cd20
|
|
DE602004027483D1
(de)
|
2003-05-23 |
2010-07-15 |
Crucell Holland Bv |
Herstellung von rekombinanten igm in den per.c6 zellen
|
|
TW200510532A
(en)
|
2003-07-15 |
2005-03-16 |
Chugai Pharmaceutical Co Ltd |
IgM production by transformed cell and method of quantifying the same
|
|
EP2216342B1
(en)
|
2003-07-31 |
2015-04-22 |
Immunomedics, Inc. |
Anti-CD19 antibodies
|
|
US8147832B2
(en)
|
2003-08-14 |
2012-04-03 |
Merck Patent Gmbh |
CD20-binding polypeptide compositions and methods
|
|
US7803914B2
(en)
|
2003-10-09 |
2010-09-28 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for stabilizing protein solutions
|
|
JP4948174B2
(ja)
|
2003-10-16 |
2012-06-06 |
マイクロメット アクツィエン ゲゼルシャフト |
多重特異的脱免疫ｃｄ３−結合物質
|
|
FR2861255B1
(fr)
|
2003-10-24 |
2006-02-17 |
Centre Nat Rech Scient |
Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications.
|
|
WO2005077981A2
(en)
|
2003-12-22 |
2005-08-25 |
Xencor, Inc. |
Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES
|
|
US7850962B2
(en)
|
2004-04-20 |
2010-12-14 |
Genmab A/S |
Human monoclonal antibodies against CD20
|
|
WO2006052641A2
(en)
|
2004-11-05 |
2006-05-18 |
Palingen, Inc. |
Antibody induced cell membrane wounding
|
|
US7251164B2
(en)
|
2004-11-10 |
2007-07-31 |
Innovative Silicon S.A. |
Circuitry for and method of improving statistical distribution of integrated circuits
|
|
WO2006063067A2
(en)
|
2004-12-09 |
2006-06-15 |
La Jolla Institute For Allergy And Immunology |
Novel tnf receptor regulatory domain
|
|
CA2599734C
(en)
|
2005-03-03 |
2014-01-28 |
Immunomedics, Inc. |
Humanized l243 antibodies
|
|
US8349332B2
(en)
|
2005-04-06 |
2013-01-08 |
Ibc Pharmaceuticals, Inc. |
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
|
|
US20070014720A1
(en)
|
2005-06-02 |
2007-01-18 |
Gadi Gazit-Bornstein |
Antibodies directed to CD20 and uses thereof
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
TW200732350A
(en)
|
2005-10-21 |
2007-09-01 |
Amgen Inc |
Methods for generating monovalent IgG
|
|
RU2008129827A
(ru)
|
2005-12-21 |
2010-01-27 |
МЕДИММЬЮН, ЭлЭлСи (US) |
МОЛЕКУЛЫ EphA2-BiTE И ИХ ПРИМЕНЕНИЕ
|
|
EP2016173A4
(en)
|
2006-05-15 |
2010-06-09 |
Immunomedics Inc |
METHOD AND COMPOSITIONS FOR TREATING HUMAN IMMUNODEFECT VIRUS INFECTIONS WITH CONJUGATED ANTIBODIES OR ANTIBODY FRAGMENTS
|
|
EP2021500B1
(en)
|
2006-05-19 |
2014-12-31 |
Children, Youth and Women's Health Service |
Selective modulation of receptor signalling
|
|
EP2418223A3
(en)
|
2006-06-12 |
2013-01-16 |
Emergent Product Development Seattle, LLC |
Single-chain multivalent binding proteins with effector function
|
|
EP2066337A2
(en)
*
|
2006-08-04 |
2009-06-10 |
Amylin Pharmaceuticals, Inc. |
Use of exendins, exendin agonists and glp-1 receptor agonists for altering the concentration of fibrinogen
|
|
KR101544108B1
(ko)
|
2006-09-08 |
2015-08-13 |
애브비 바하마스 리미티드 |
인터루킨-13 결합 단백질
|
|
US9382327B2
(en)
|
2006-10-10 |
2016-07-05 |
Vaccinex, Inc. |
Anti-CD20 antibodies and methods of use
|
|
NZ576445A
(en)
|
2006-11-02 |
2012-03-30 |
Daniel J Capon |
Hybrid immunoglobulins with moving parts
|
|
US20080145420A1
(en)
*
|
2006-12-13 |
2008-06-19 |
Simon Michael R |
HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
|
|
EP2087111A2
(en)
*
|
2007-03-19 |
2009-08-12 |
Medimmune Limited |
Polypeptide variants
|
|
US20100298223A1
(en)
|
2007-05-02 |
2010-11-25 |
Dietmar Rudolf Fries |
Fibrinogen for treatment of bleeding in trauma and platelet disorders
|
|
WO2009013620A2
(en)
|
2007-06-11 |
2009-01-29 |
Erasmus University Medical Center Rotterdam |
Homologous recombination
|
|
EP2195342A1
(en)
|
2007-09-07 |
2010-06-16 |
Ablynx N.V. |
Binding molecules with multiple binding sites, compositions comprising the same and uses thereof
|
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
EP2219458B1
(en)
|
2007-11-08 |
2015-07-15 |
Cytimmune Sciences, Inc. |
Compositions and methods for generating antibodies
|
|
EP2254592B1
(en)
|
2008-02-28 |
2019-06-05 |
Dako Denmark A/S |
Mhc multimers in borrelia diagnostics and disease
|
|
ITTO20080313A1
(it)
|
2008-04-22 |
2009-10-23 |
Marco Colombatti |
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi
|
|
CN102149727A
(zh)
|
2008-07-11 |
2011-08-10 |
航道生物技术有限责任公司 |
包含抗体替代卡帕轻链序列的构建体和文库
|
|
US10369204B2
(en)
|
2008-10-02 |
2019-08-06 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
DK2356270T3
(da)
|
2008-11-07 |
2016-12-12 |
Fabrus Llc |
Kombinatoriske antistofbiblioteker og anvendelser deraf
|
|
JP5739865B2
(ja)
*
|
2009-03-24 |
2015-06-24 |
バイエル・ヘルスケア・エルエルシー |
第ｖｉｉｉ因子変異体および使用の方法
|
|
EP2509997B1
(en)
|
2009-12-07 |
2017-08-30 |
i2 Pharmaceuticals, Inc. |
Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties
|
|
SG181952A1
(en)
|
2009-12-29 |
2012-07-30 |
Emergent Product Dev Seattle |
Heterodimer binding proteins and uses thereof
|
|
WO2011100403A1
(en)
|
2010-02-10 |
2011-08-18 |
Immunogen, Inc |
Cd20 antibodies and uses thereof
|
|
US9085623B2
(en)
|
2010-02-11 |
2015-07-21 |
Alexion Pharmaceuticals, Inc. |
Therapeutic methods using anti-CD200 antibodies
|
|
WO2012054077A2
(en)
|
2010-10-19 |
2012-04-26 |
Mayo Foundation For Medical Education And Research |
Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease
|
|
US20120195900A1
(en)
|
2010-12-22 |
2012-08-02 |
Abbott Laboratories |
Tri-variable domain binding proteins and uses thereof
|
|
MX2014004980A
(es)
|
2011-10-24 |
2014-09-11 |
Abbvie Inc |
Inmunoaglutinantes biespecificos dirigidos contra tnf e il-17.
|
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
GB201122047D0
(en)
|
2011-12-21 |
2012-02-01 |
Kymab Ltd |
Transgenic animals
|
|
US20140359902A1
(en)
|
2011-12-16 |
2014-12-04 |
Synthon Biopharmaceuticals B.V. |
EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED
|
|
CA2863714C
(en)
|
2012-02-08 |
2022-07-05 |
Igm Biosciences, Inc. |
Cdim binding proteins and uses thereof
|
|
AU2013244916B2
(en)
|
2012-04-05 |
2017-08-03 |
Gottfried Himmler |
Secretory immunoglobulin complex
|
|
ES2655077T3
(es)
|
2012-04-17 |
2018-02-16 |
Mayo Foundation For Medical Education And Research |
Anticuerpos humanos y secuencias de unión específicos del mismo para uso en accidente cerebrovascular e isquemia y condiciones isquémicas
|
|
KR102177252B1
(ko)
|
2012-04-23 |
2020-11-10 |
가부시키가이샤 에스 앤드 케이 바이오파마 |
락토페린 융합 단백질 및 그의 제조방법
|
|
US20150175678A1
(en)
|
2012-06-15 |
2015-06-25 |
Beth Israel Deaconess Medical Center, Inc. |
IgA CD4i ANTIBODIES AND METHODS OF TREATMENT USING SAME
|
|
WO2014022592A1
(en)
|
2012-08-02 |
2014-02-06 |
Jn Biosciences Llc |
Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece
|
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
|
WO2014124457A1
(en)
|
2013-02-11 |
2014-08-14 |
University Of Louisville Research Foundation, Inc. |
Methods for producing antibodies
|
|
US9487773B2
(en)
|
2013-03-01 |
2016-11-08 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Cell-based methods for coupling protein interactions and binding molecule selection
|
|
EP2968587A2
(en)
*
|
2013-03-13 |
2016-01-20 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto
|
|
GB201311487D0
(en)
|
2013-06-27 |
2013-08-14 |
Alligator Bioscience Ab |
Bispecific molecules
|
|
US20150038682A1
(en)
|
2013-08-02 |
2015-02-05 |
Jn Biosciences Llc |
Antibodies or fusion proteins multimerized via homomultimerizing peptide
|
|
CA2922830A1
(en)
|
2013-09-05 |
2015-04-16 |
Igm Biosciences, Inc. |
Constant chain modified bispecific, penta- and hexavalent ig-m antibodies
|
|
WO2015037000A1
(en)
|
2013-09-11 |
2015-03-19 |
Compugen Ltd |
Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseases
|
|
NZ720353A
(en)
|
2013-12-30 |
2019-12-20 |
Epimab Biotherapeutics Inc |
Fabs-in-tandem immunoglobulin and uses thereof
|
|
CA2936877C
(en)
|
2014-01-16 |
2023-03-28 |
Mario Umberto Francesco MONDELLI |
Neutralizing human monoclonal antibodies against hepatitis b virus surface antigen
|
|
AU2015213593B2
(en)
|
2014-02-10 |
2020-09-03 |
Igm Biosciences, Inc. |
IgA multi-specific binding molecules
|
|
TWI777174B
(zh)
|
2014-03-14 |
2022-09-11 |
瑞士商諾華公司 |
針對lag-3之抗體分子及其用途
|
|
KR102380402B1
(ko)
|
2014-04-03 |
2022-03-31 |
아이쥐엠 바이오사이언스 인코포레이티드 |
변형된 j-사슬
|
|
EP3750918A1
(en)
|
2015-01-20 |
2020-12-16 |
IGM Biosciences, Inc. |
Tumor necrosis factor (tnf) superfamily receptor binding molecules and uses thereof
|
|
CN115093479A
(zh)
|
2015-03-04 |
2022-09-23 |
Igm生物科学股份有限公司 |
Cd20结合分子及其用途
|
|
JP6882184B2
(ja)
|
2015-03-25 |
2021-06-02 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
多価ｂ型肝炎ウイルス抗原結合分子およびその使用
|
|
WO2016168758A1
(en)
|
2015-04-17 |
2016-10-20 |
Igm Biosciences, Inc. |
Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof
|
|
NZ739830A
(en)
|
2015-07-12 |
2021-12-24 |
Hangzhou Dac Biotech Co Ltd |
Bridge linkers for conjugation of cell-binding molecules
|
|
US11639389B2
(en)
|
2015-09-30 |
2023-05-02 |
Igm Biosciences, Inc. |
Binding molecules with modified J-chain
|
|
DK3355913T3
(da)
|
2015-09-30 |
2024-12-02 |
Igm Biosciences Inc |
Bindingsmolekyler med modificeret j-kæde
|
|
PL3455257T3
(pl)
|
2016-05-09 |
2022-01-17 |
Igm Biosciences Inc. |
Przeciwciała anty-pd-l1
|
|
US20190330374A1
(en)
|
2016-07-20 |
2019-10-31 |
Igm Biosciences, Inc. |
Multimeric ox40 binding molecules and uses thereof
|
|
US20190330360A1
(en)
|
2016-07-20 |
2019-10-31 |
Igm Biosciences, Inc. |
Multimeric gitr binding molecules and uses thereof
|
|
US20190338040A1
(en)
|
2016-07-20 |
2019-11-07 |
Igm Biosciences, Inc. |
Multimeric cd137/4-1bb binding molecules and uses thereof
|
|
EP3496536A4
(en)
|
2016-07-20 |
2020-02-12 |
IGM Biosciences, Inc. |
MULTIMERE CD40-BINDING MOLECULES AND USES THEREOF
|
|
US11401337B2
(en)
|
2017-04-07 |
2022-08-02 |
Igm Biosciences, Inc. |
Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function
|
|
US20200392239A1
(en)
|
2018-02-26 |
2020-12-17 |
Igm Biosciences, Inc. |
Use of a multimeric anti-dr5 binding molecule in combination with a chemotherapeutic agent for treating cancer
|
|
WO2019169314A1
(en)
|
2018-03-01 |
2019-09-06 |
Igm Biosciences, Inc. |
IgM Fc AND J-CHAIN MUTATIONS THAT AFFECT IgM SERUM HALF-LIFE
|
|
KR20210083260A
(ko)
|
2018-10-23 |
2021-07-06 |
아이쥐엠 바이오사이언스 인코포레이티드 |
다가 IgM- 및 IgA-Fc 기반 결합 분자
|
|
US20220106398A1
(en)
|
2019-02-08 |
2022-04-07 |
Igm Biosciences, Inc. |
Anti-gitr antigen-binding domains and uses thereof
|
|
CN114269785A
(zh)
|
2019-08-15 |
2022-04-01 |
Igm生物科学股份有限公司 |
免疫刺激性多聚体结合分子
|
|
KR20220045030A
(ko)
|
2019-08-17 |
2022-04-12 |
아이쥐엠 바이오사이언스 인코포레이티드 |
다량체성 이중특이적 항-cd123 결합 분자 및 이의 용도
|
|
BR112022003282A2
(pt)
|
2019-08-23 |
2022-05-24 |
Igm Biosciences Inc |
Glicovariantes de igm
|
|
AU2020351205A1
(en)
|
2019-09-19 |
2022-04-14 |
Igm Biosciences, Inc. |
Multimeric antibodies with enhanced selectivity for cells with high target density
|
|
BR112022013071A2
(pt)
|
2020-01-06 |
2022-09-20 |
Igm Biosciences Inc |
Moléculas de ligação multiméricas altamente sialiladas
|
|
US20230212293A1
(en)
|
2020-04-22 |
2023-07-06 |
Igm Biosciences, Inc. |
Pd-1 agonist multimeric binding molecules
|
|
MX2022014259A
(es)
|
2020-05-12 |
2022-12-07 |
Igm Biosciences Inc |
Uso de una molecula de union anti-dr5 multimerica en combinacion con una terapia contra el cancer para tratar el cancer.
|
|
CA3187008A1
(en)
|
2020-07-27 |
2022-02-03 |
Paul R. Hinton |
Multimeric coronavirus binding molecules and uses thereof
|
|
US20240002526A1
(en)
|
2020-11-17 |
2024-01-04 |
Igm Biosciences, Inc. |
Uses of effector cell engaging molecules with moieties of differing potencies
|
|
MX2023009615A
(es)
|
2021-02-17 |
2023-08-24 |
Igm Biosciences Inc |
Moleculas de union anti-cd123 y usos de estas.
|
|
WO2022177870A1
(en)
|
2021-02-17 |
2022-08-25 |
The Board Of Regents Of The University Of Texas System |
Multimeric sars-cov-2 binding molecules and uses thereof
|
|
WO2023064766A1
(en)
|
2021-10-11 |
2023-04-20 |
Igm Biosciences, Inc. |
Lateral flow device and uses thereof
|
|
WO2023064900A1
(en)
|
2021-10-15 |
2023-04-20 |
Igm Biosciences, Inc. |
Methods of use of multimeric anti-pd-l1 binding molecules
|
|
JP2025506341A
(ja)
|
2022-02-03 |
2025-03-11 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
抗ｃｄ３８結合分子及びその使用
|
|
WO2023178253A2
(en)
|
2022-03-18 |
2023-09-21 |
Igm Biosciences, Inc. |
Use of a multimeric anti-pd-l1 binding molecule in combination with a monoclonal antibody therapy
|
|
WO2024073700A2
(en)
|
2022-09-30 |
2024-04-04 |
Igm Biosciences, Inc. |
Methods of treating autoimmune disorders using multimeric anti-cd20/anti-cd3 antibodies
|
|
WO2024138072A1
(en)
|
2022-12-22 |
2024-06-27 |
Igm Biosciences, Inc. |
Methods of treating autoimmune disorders using multimeric anti-cd38/anti-cd3 antibodies
|
|
JP2026502759A
(ja)
|
2023-01-06 |
2026-01-27 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
Ｔ細胞共刺激多量体結合分子及びその使用
|
|
WO2024148339A1
(en)
|
2023-01-06 |
2024-07-11 |
Igm Biosciences, Inc. |
Use of a multimeric anti-dr5 antibody for treating cancer
|
|
WO2024229151A2
(en)
|
2023-05-02 |
2024-11-07 |
Igm Biosciences, Inc. |
Multimeric coronavirus binding molecules and uses thereof
|